⚡ Quick Answer
What is the hernia mesh lawsuit? Thousands of patients who received hernia mesh implants from manufacturers including C.R. Bard, Covidien, Ethicon, and Atrium have filed lawsuits alleging the devices were defectively designed and caused chronic pain, infection, mesh migration, bowel obstruction, organ damage, and the need for revision surgery. In October 2024, Bard's parent company Becton Dickinson settled approximately 38,000 cases for over $1 billion. Despite this, over 26,000 hernia mesh lawsuits remain pending — primarily against Bard (for new claimants and opt-outs) and Covidien, whose first bellwether trials begin in 2026.
Who Qualifies for a Hernia Mesh Lawsuit
Eligibility focuses on patients who received a hernia mesh implant and subsequently suffered serious complications — particularly those requiring additional surgery or causing chronic, debilitating symptoms. Cases involving Bard and Covidien products are the most active.
Qualifying Criteria:
How Hernia Mesh Caused Harm — What Manufacturers Are Accused Of
Hernia mesh lawsuits allege that manufacturers produced polypropylene mesh devices with known design defects that made them prone to failure inside the body — and failed to adequately warn surgeons and patients about these risks. Four core patterns of misconduct are alleged across active cases:
1. Defective Design — Polypropylene Degrades and Triggers Immune Reactions
The polypropylene plastic used in hernia mesh is alleged to be inherently prone to degradation inside the body over time, causing the mesh to shrink, stiffen, and become brittle. As it degrades, it can trigger chronic inflammatory responses and cause surrounding tissue to harden. Lawsuits allege manufacturers chose polypropylene as a cost-effective material despite awareness of these degradation risks.
2. Mesh Migration — Devices Move from Implant Site and Damage Nearby Organs
Defective hernia mesh can pull away from the tissue it was anchored to and migrate to adjacent areas of the abdomen. When mesh migrates, it can adhere to or perforate the intestines, bladder, or other organs — causing potentially life-threatening complications and requiring emergency surgery to remove. Lawsuits allege the mesh's pore structure and fixation system made migration foreseeable and preventable.
3. Failure to Warn Surgeons and Patients About Known Risks
Lawsuits allege that mesh manufacturers were aware of post-market adverse event reports documenting serious complications but failed to update product labeling, issue adequate warnings to surgeons, or notify patients that their implanted device was associated with elevated complication rates. Bellwether trial evidence in the Bard MDL revealed internal corporate awareness of mesh failure data that was not communicated to the medical community.
4. Inadequate Pre-Market Testing
Several hernia mesh products reached the market through the FDA's 510(k) clearance pathway — a process that does not require clinical trials proving a device is safe, only that it is "substantially equivalent" to a previously marketed device. Lawsuits allege that manufacturers took advantage of this lower regulatory bar, bringing products to market without adequate long-term safety data on degradation, migration, or immune response in human patients.
Complications & Injuries Recognized in Active Claims
The strongest hernia mesh cases involve serious, documented complications that required medical treatment or surgical intervention. Be alert for these symptoms — mesh complications can emerge slowly, months or even years after the original surgery.
Settlement Amounts & What Affects Your Claim Value
The Bard settlement program uses a tiered, points-based system. Covidien has not settled, and bellwether trials in 2026 will shape those values. Key factors that affect compensation across all hernia mesh claims:
- 🔴
Need for revision or removal surgery — Cases requiring additional surgery are significantly higher-value. Multiple revision surgeries substantially increase claim value.
- 🔴
Severity and permanence of complications — Organ perforation, fistulas, chronic infections requiring long-term treatment, and permanent disability yield significantly higher values than pain alone.
- 📋
Medical documentation quality — Operative reports identifying the specific mesh product, post-operative records documenting complications, pathology confirming mesh-related tissue damage, and imaging are all critical to claim value.
- 💼
Lost income and economic damages — Time missed from work for surgery, recovery, and ongoing care adds economic damages on top of non-economic compensation.
- ⚖️
Which manufacturer and MDL — Bard claims are processed through the established settlement program (Quick-Pay or Traditional Pay). Covidien claims are approaching bellwether trials and analysts expect potentially higher settlement values given the severity of alleged Covidien injuries.
- 💀
Wrongful death — Cases involving death from mesh-related complications carry the highest potential values and are evaluated individually based on state wrongful death law.
Quick-Pay Option: $2,500 – $25,000 — Faster payout, lower amount, no points review
Traditional Pay Option: $60,000 – $100,000+ — Points-based review of injury severity; higher amounts for severe cases
Jury Verdict Benchmarks (Bard bellwether trials):
$500,000 — Aaron Stinson (PerFix Plug, Ohio)
$4.8 million — Paul Trevino (Ventralex, Rhode Island)
Covidien: No settlement reached; first bellwether trial July 13, 2026. Legal analysts expect Covidien settlements to exceed Bard amounts given the severity of alleged injuries.
Disclaimer: Settlement amounts are confidential. Ranges are based on published court orders and jury verdict reports and are educational only — not a guarantee of outcome. Actual results depend on case-specific facts and litigation developments.
Filing Deadlines by State
Every state has statutes of limitations for product liability claims — typically 2 to 3 years. Critically, most states apply a discovery rule that starts the clock when you knew or reasonably should have known that your complications were caused by the mesh — not the date of the original surgery. This is particularly important for hernia mesh, where complications can emerge 2–5 years post-implantation. Missing your deadline permanently bars your claim.
| State | Standard SOL | Discovery Rule | Notes |
|---|---|---|---|
| Ohio | 2 years | Yes | Home of Bard MDL-2846; bellwether verdict ($500K) set in Columbus; active docket |
| Massachusetts | 3 years | Yes | Home of Covidien MDL-3029; first bellwether trial July 13, 2026; second bellwether also July 2026 |
| Rhode Island | 3 years | Yes | State court venue for Bard; $4.8M Rhode Island jury verdict (Ventralex); settlement cases coordinated here |
| California | 2 years | Yes | Active individual and state court filings; discovery rule commonly applied to mesh complications |
| New York | 3 years | Yes | Longer standard SOL; individual filings active |
| Texas | 2 years | Yes | Active filings; wrongful death claims must be filed within 2 years of death |
| Florida | 2 years | Yes | SOL recently shortened from 4 to 2 years; act immediately if your complications emerged before 2023 |
| All Other States | Typically 2–3 years | Varies | Active cases filed in all 50 states. Do not assume it is too late — the discovery rule may significantly extend your window. |
Hernia Mesh Lawsuit Updates — 2026
Last updated June 2026. We update this section monthly with new MDL case counts, trial dates, settlement developments, and court rulings.
-
March 2026 Latest26,263 Cases Pending Across All MDLs; Covidien Bellwether Moved to July 2026: As of March 2026, approximately 26,263 hernia mesh lawsuits are pending across all MDLs — Bard (approximately 23,749 pending), Covidien (2,348+), Atrium (approximately 436, winding down), and Ethicon (minimal residual cases). The Covidien first bellwether trial, originally scheduled for February 17, 2026, has been postponed to July 13, 2026, giving parties additional time to explore settlement before trial. A second Covidien bellwether trial is also set for July 2026. Attorneys widely expect Covidien settlement amounts will ultimately exceed Bard's given the severity of injuries alleged in Covidien cases.
-
February 2026Bard MDL Procedural Dismissal Highlights Importance of Attorney Representation: The federal judge overseeing the Bard MDL dismissed an individual lawsuit after the plaintiff failed to serve the complaint within the required timeframe. The case was dismissed without prejudice — meaning the claims themselves were not rejected and may be refiled. The dismissal underscores how critical it is to work with an experienced hernia mesh attorney who can ensure procedural requirements are met and deadlines are not missed.
-
December 9, 2025Bard MDL Adds 113 New Cases, Reaching 23,818 Pending: The Bard hernia mesh MDL added 113 new cases in December — a sign that new claimants with delayed complications are still actively joining the litigation even after the October 2024 settlement announcement. New cases filed after the settlement cutoff are not covered by the earlier agreement and will be addressed through the Intensive Settlement Process beginning January 2027.
-
August 21, 2025Covidien Settlement Deadline Extended Four Months to January 2026: Judge Patti Saris granted Covidien and Medtronic four additional months to participate in mediation, extending the global settlement deadline to January 14, 2026. The February 2026 first bellwether trial date remained intact as the primary pressure point for settlement movement — though that trial has since been further postponed to July 2026. Plaintiffs want trials to move forward; Covidien's continued resistance to settlement signals the litigation may need to proceed through trial.
-
July 29, 2025Strattice Biologic Mesh Litigation Gains Prominence: Strattice biologic mesh litigation — focusing on porcine-tissue mesh products — is growing. Plaintiffs allege Strattice causes chronic infections and tissue degradation similar to synthetic mesh, despite being marketed as a safer alternative. The FDA has received over 450 adverse event reports for Strattice including hundreds of injuries and multiple deaths. Federal proceedings are managed by U.S. Magistrate Judge Leda Wettre in the District of New Jersey.
-
July 10, 2025Bard ISP Timeline Clarified — Settlement Process Begins January 2027, Opt-Out Option June 2029: The formal Intensive Settlement Process (ISP) for unresolved Bard claims is not scheduled to begin until January 2027. Monthly settlement conferences and mediations will run through June 2029. Claimants not resolved by June 2029 may opt out of the settlement process and resume individual litigation. Claimants who settled under the October 2024 agreement are proceeding through the Qualified Settlement Fund now.
-
May 15, 2025Bard Settlement Structure Confirmed — ~38,000 Cases, $1B+ Total, Two Payment Tiers: Around 38,000 Bard hernia mesh lawsuits have been resolved with a total settlement value estimated over $1 billion. Special Masters oversee administration, with payments scheduled to begin in 2025 and continue over several years. The settlement offers a Quick-Pay option ($2,500–$25,000 for faster resolution) and a Traditional Pay option ($60,000–$100,000+ for severe injuries evaluated on a points basis). Plaintiffs may opt out to pursue individual litigation, though trials may be delayed.
-
December 3, 2024Intensive Settlement Process Established; Special Masters Appointed; QSF Funded: Case Management Order No. 55 established the Intensive Settlement Process (ISP) to facilitate resolution of remaining hernia mesh lawsuits. Ellen K. Reisman and John Jackson were appointed Special Masters. Separately, Case Management Order No. 56 established a Qualified Settlement Fund (QSF) managed by Wells Fargo to receive and distribute settlement payments. The QSF structure helps untangle Medicare/Medicaid liens before distributions reach plaintiffs.
-
October 4, 2024Becton Dickinson Announces $1B+ Settlement to Resolve ~38,000 Bard Hernia Mesh Lawsuits: BD (Becton, Dickinson and Company), C.R. Bard's parent company, announced it had reached a settlement to resolve the majority of ongoing hernia mesh lawsuits consolidated in Ohio and Rhode Island courts. The settlement is estimated to exceed $1 billion in total value. The agreement covers approximately 93% of existing Bard claimants. New cases filed after the settlement date are being processed through separate channels.
-
Bellwether Trial ResultsBard Jury Verdict Record — $500K to $4.8M: Three Bard bellwether trials were completed before the October 2024 settlement. Results ranged from $500,000 (Aaron Stinson, PerFix Plug, Ohio — nerve pain requiring mesh revision) to $4.8 million (Paul Trevino, Ventralex, Rhode Island — multiple complications and revision surgeries). These verdicts directly informed the Bard global settlement value and continue to serve as benchmarks for individual case valuation within the settlement program.
Your Hernia Mesh Should Have Healed You — Find Out If You Have a Claim
New hernia mesh lawsuits are filed every month. Attorneys are actively accepting Bard and Covidien cases. You pay nothing unless compensation is recovered.
Start My Free Case ReviewHow the Hernia Mesh Lawsuit Process Works
Attorneys handle hernia mesh cases on contingency — you pay nothing unless compensation is recovered.
- Free confidential consultation — Share your surgical history, mesh product (if known), and complications with an attorney at no cost. You don't need your medical records in hand before reaching out.
- Case review and evidence gathering — Your attorney requests operative reports identifying the mesh manufacturer and product, post-operative records documenting complications, pathology reports, imaging, and any revision surgery records.
- Identifying the defendant — Your attorney confirms which manufacturer is responsible (Bard, Covidien, Ethicon, Atrium, or another). This determines whether your claim falls into the existing Bard settlement program, the Covidien MDL, or a state court filing.
- Filing the lawsuit or settlement claim — For Bard claims, your attorney files through the settlement program (Quick-Pay or Traditional Pay). For Covidien and other pending cases, your attorney files in the appropriate MDL or state court.
- Discovery — Both sides exchange evidence: manufacturer internal testing data, post-market surveillance reports, communications about known mesh failure rates, and marketing materials.
- Expert testimony — Surgeons, biomedical engineers, and materials scientists testify about mesh design defects, degradation, and causation — linking your specific complications to the device's known failure modes.
- Settlement negotiations or trial — Bard claims enter the established settlement payment process. Covidien cases are heading toward bellwether trials in July 2026, which will shape settlement values for the broader Covidien MDL. Most cases are expected to resolve through settlement.
- Compensation distributed — If your case settles or a verdict is reached, your attorney is paid a contingency fee (typically 33–40%). If they don't recover, you owe nothing. Medicare/Medicaid lien resolution may affect the timeline of your net payment.
Frequently Asked Questions
Who qualifies for a hernia mesh lawsuit?
You may qualify if you had hernia mesh surgery involving a Bard, Covidien, Ethicon, or Atrium product and suffered serious complications — chronic pain, infection, mesh migration, bowel obstruction, organ perforation, hernia recurrence, or the need for revision or removal surgery.
Cases against Bard and Covidien are the most active. Attorneys are still accepting new cases in all 50 states, including from patients with delayed complications who did not know their symptoms were mesh-related until recently.
Has Bard (Becton Dickinson) settled the hernia mesh lawsuit?
Yes. In October 2024, Becton Dickinson agreed to resolve approximately 38,000 Bard hernia mesh lawsuits for a total estimated value exceeding $1 billion. A Qualified Settlement Fund was established and settlement payments began in 2025.
However, new cases filed after the settlement cutoff are not covered and will be addressed through the Intensive Settlement Process beginning January 2027. Attorneys continue to accept new Bard cases from patients with newly emerging complications.
What is the status of the Covidien hernia mesh lawsuit?
The Covidien (Medtronic) hernia mesh MDL has over 2,348 active cases pending in Massachusetts. Covidien has not settled. The first bellwether trial, involving an Alabama plaintiff and Parietex Optimized Composite Mesh, is scheduled for July 13, 2026. A second bellwether trial is also scheduled for July 2026. Legal analysts expect Covidien settlement amounts to exceed Bard's given the severity of injuries alleged in Covidien cases.
How much is a hernia mesh lawsuit worth?
The Bard settlement offers Quick-Pay ($2,500–$25,000) and Traditional Pay ($60,000–$100,000+ for severe injuries) options. Bard bellwether jury verdicts ranged from $500,000 to $4.8 million. Legal analysts estimate average individual payouts of $50,000–$200,000+.
Covidien cases have not settled yet and jury verdicts in July 2026 bellwether trials will help establish settlement benchmarks. Cases requiring multiple revision surgeries, involving organ damage, or resulting in wrongful death typically yield the highest values.
Which hernia mesh brands are involved in lawsuits?
The most active litigation involves Bard/Davol products — Ventralight, Ventralex, PerFix Plug, and 3DMax — and Covidien products — Parietex Optimized Composite Mesh and Symbotex. The Ethicon (Physiomesh, Proceed) and Atrium (C-Qur) MDLs are largely winding down after settlements.
If you are unsure which brand you received, your surgeon's operative report or hospital implant records will identify the manufacturer and product. Your attorney can request these records directly from the hospital.
Is there a deadline to file a hernia mesh lawsuit?
Yes, but the deadline may be later than you think. Most states allow 2–3 years from when you discovered (or reasonably should have discovered) that your complications were caused by the mesh — not from the date of your original surgery. This discovery rule is particularly important for hernia mesh, where complications commonly emerge 1–5 years post-implantation.
Do not assume it is too late because your surgery was several years ago. Speak to an attorney immediately to confirm your specific state's deadline.
What is the Bard Intensive Settlement Process (ISP)?
The Intensive Settlement Process (ISP) is a structured framework established by Case Management Order No. 55 (December 2024) to resolve remaining Bard hernia mesh claims that were not part of the October 2024 global settlement. Special Masters Ellen K. Reisman and John Jackson oversee monthly settlement conferences and mediations. The ISP begins in January 2027 and runs through June 2029. Claimants unresolved by June 2029 may opt out and pursue individual litigation.
